Elisabet de Los Pinos - 27 Sep 2024 Form 4 Insider Report for Aura Biosciences, Inc. (AURA)

Role
President and Chief Executive Officer; Exhibit 24.1 - Power of Attorney, Director
Signature
/s/ Conor Kilroy, as Attorney-in-Fact
Issuer symbol
AURA
Transactions as of
27 Sep 2024
Net transactions value
+$31,530
Form type
4
Filing time
01 Oct 2024, 17:08:53 UTC
Previous filing
02 Feb 2024
Next filing
18 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AURA Common Stock Options Exercise $31,530 +5,474 +1.7% $5.76 329,847 27 Sep 2024 Direct F1
holding AURA Common Stock 131,412 27 Sep 2024 By EdIP Revocable Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AURA Stock Option (Right to Buy) Options Exercise $0 -5,474 -100% $0.000000 0 27 Sep 2024 Common Stock 5,474 $5.76 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 27, 2024, the Reporting Person exercised long held stock options to purchase 5,474 shares of the Issuer's common stock, as they were set to expire on October 1, 2024.
F2 The shares are held by the Elisabet de los Pinos Revocable Trust U/D/T dated April 8, 2016, of which the Reporting Person is a trustee.
F3 This option is fully vested.

Remarks:

President and Chief Executive Officer; Exhibit 24.1 - Power of Attorney